MiR-153 inhibits migration and invasion of human non-small-cell lung cancer by targeting ADAM19.


MiR-153 was reported to be dysregulated in some human cancers. However, the function and mechanism of miR-153 in lung cancer cells remains unknown. In this study, we investigated the role of miR-153 in human non-small-cell lung cancer (NSCLC). Using qRT-PCR, we demonstrated that miR-153 was significantly decreased in clinical NSCLC tissues and cell lines… (More)
DOI: 10.1016/j.bbrc.2014.11.093


Blog articles referencing this paper

  • RNAi

    Pharmaceutical Intelligence · Mar 26, 2015

  • Don't see an article that should be here?